The Venture Codex Logo

The Venture Codex

Overview

Specialty pharmaceutical company focused on neurology and psychiatry.

Founded

2003

Deals ยท 12mo

0

Stage focus

Series A
Series B

Geographic focus

The Netherlands
United States

Sector focus

Biotechnology
Health Care
Pharmaceutical

Investment portfolio

3rounds
NAMEDATESIZE
Onera Health
Jul 2021Participated
$12 MSeries B
Onera Health
Apr 2019Participated
$9 MSeries A
Arrivo BioVentures LLC
May 2016Led
$49 MOther Equity
Onera Health
Jul 2021Participated
$12 MSeries B
Onera Health
Apr 2019Participated
$9 MSeries A
Arrivo BioVentures LLC
May 2016Led
$49 MOther Equity
3
Items
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Jazz Pharmaceuticals: 3 funding rounds are recorded in the selected participation categories.All available history.
Jazz Pharmaceuticals: 3 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Series A01
Series B01
Other Equity10

Monthly Deal Activity

Jazz Pharmaceuticals: 3 deals are recorded across 126 months.All available history.
Jazz Pharmaceuticals: 3 deals are recorded across 126 months. All available history
MonthDeals
May '161
Jun '160
Jul '160
Aug '160
Sep '160
Oct '160
Nov '160
Dec '160
Jan '170
Feb '170
Mar '170
Apr '170
May '170
Jun '170
Jul '170
Aug '170
Sep '170
Oct '170
Nov '170
Dec '170
Jan '180
Feb '180
Mar '180
Apr '180
May '180
Jun '180
Jul '180
Aug '180
Sep '180
Oct '180
Nov '180
Dec '180
Jan '190
Feb '190
Mar '190
Apr '191
May '190
Jun '190
Jul '190
Aug '190
Sep '190
Oct '190
Nov '190
Dec '190
Jan '200
Feb '200
Mar '200
Apr '200
May '200
Jun '200
Jul '200
Aug '200
Sep '200
Oct '200
Nov '200
Dec '200
Jan '210
Feb '210
Mar '210
Apr '210
May '210
Jun '210
Jul '211
Aug '210
Sep '210
Oct '210
Nov '210
Dec '210
Jan '220
Feb '220
Mar '220
Apr '220
May '220
Jun '220
Jul '220
Aug '220
Sep '220
Oct '220
Nov '220
Dec '220
Jan '230
Feb '230
Mar '230
Apr '230
May '230
Jun '230
Jul '230
Aug '230
Sep '230
Oct '230
Nov '230
Dec '230
Jan '240
Feb '240
Mar '240
Apr '240
May '240
Jun '240
Jul '240
Aug '240
Sep '240
Oct '240
Nov '240
Dec '240
Jan '250
Feb '250
Mar '250
Apr '250
May '250
Jun '250
Jul '250
Aug '250
Sep '250
Oct '250
Nov '250
Dec '250
Jan '260
Feb '260
Mar '260
Apr '260
May '260
Jun '260
Jul '260
Aug '260
Sep '260
Oct '260

Sector Breakdown

Jazz Pharmaceuticals: Health & Life Sciences is the largest displayed sector by deal count (3 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Jazz Pharmaceuticals: Health & Life Sciences is the largest displayed sector by deal count (3 deals). All available history
SectorDeals
Health & Life Sciences3
Hardware & Robotics2
Space & Frontier Tech2

Deal Size Distribution

Jazz Pharmaceuticals: 3 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Jazz Pharmaceuticals: 3 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M0
$5M-$10M1
$10M-$25M1
$25M-$50M1
$50M-$100M0
$100M-$250M0
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

Jazz Pharmaceuticals: Europe has the largest recorded deal count among the displayed regions (2 deals).All available history.

Top 2 of 2 regions; European countries are grouped as Europe.

Jazz Pharmaceuticals: Europe has the largest recorded deal count among the displayed regions (2 deals). All available history
RegionDeals
Europe2
United States1
Jazz Pharmaceuticals: 8 co-investors are shown, with BOM sharing 2 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Jazz Pharmaceuticals: 8 co-investors are shown, with BOM sharing 2 recorded deals. All available history
Co-investorShared deals
BOM2
imec.xpand2
15th Rock1
imec1
Innovation Industries1
Invest-NL1
Rex Health Ventures1
Solas BioVentures1

Investment Strategy

Jazz Pharmaceuticals: Led accounts for 33% and participating for 67% of round participation.All available history.
Jazz Pharmaceuticals: Led accounts for 33% and participating for 67% of round participation. All available history
CategoryDeals (count)Share (%)
Led133%
Participating267%
Jazz Pharmaceuticals: Single-lead accounts for 100% and co-led for 0% of lead dynamics.All available history.
Jazz Pharmaceuticals: Single-lead accounts for 100% and co-led for 0% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead1100%
Co-led00%

Team

Bruce Cozadd

Chief Executive Officer

Chris Tovey

Chief Operating Officer

Dennis Engelke

Executive Director, Country Manager Switzerland & Austria

Kathryn E. Falberg

Executive Vice President and Chief Financial Officer

Peter Gray

Independent Director

Ryan Bovia

Vice President, Head of Epilepsy and Movement Disorders Business Unit

Sam Pearce

Chief Commercial Officer